← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Gemcitabinhydrochlorid currently has availability issues reported in 4 European registers: Germany, Spain, Greece, Sweden.
Shortage ATC L01BC05 · also listed as: Gemcitabinhydrochlorid · GEMCITABINA · gemcitabinhydroklorid · data refreshed 14 September 2026
As of 14 September 2026, 4 of the 9 tracked registers list current availability issues for Gemcitabinhydrochlorid, covering 6 affected product presentations. The longest-running open report was filed in Germany on 2023-12-04 and has now been open for about 33 months. Where agencies state a cause, manufacturing problems lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2027-04-29; the earliest is 2026-09-29. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. The issue spread across registers over time rather than at once: Germany reported first (2023-12-04), with Greece following roughly 28 months later — a pattern typical of supply problems cascading between national markets. Registers in Germany, Spain, Greece, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Gemcitabinhydrochlorid is coded L01BC05 — a medicine acting on antineoplastic and immunomodulating agents — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇩🇪 Germany | Shortage Bendacitabin 38 mg/ml | 2023-12-04 | 2027-01-31 | Probleme in der Herstellung Alternatives: N/A | register ↗ |
| 🇪🇸 Spain | Shortage GEMCITABINA ACCORD 1500 mg CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 vial de 15 ml + 1 more productsGEMCITABINA ACCORD 2000 mg CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 20 ml | 2024-10-06 | 2026-11-29 | Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración. | register ↗ |
| 🇬🇷 Greece | Limited availability BTx1VIALx20ML + 1 more productsBTx1VIALx2ML | 2026-04-29 | 2027-04-29 | διαδικασία Εναλλακτικά άλλα σκευάσματα της ίδιας δραστικής και μορφής Alternatives: Εναλλακτικά άλλα σκευάσματα της ίδιας δραστικής, μορφής και | register ↗ |
| 🇸🇪 Sweden | Shortage Gemcitabine Accord 100 mg/ml Koncentrat till infusionsvätska, lösning | 2026-03-01 | 2026-08-31 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Gemcitabinhydrochlorid in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇪🇸 ES | GEMCITABINA ACCORD 2000 mg CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 | Shortage | 2026-08-18 | 2026-09-29 | Existen otros medicamentos con el mismo principio activo y m |
| 🇬🇷 GR | BTx1VIALx20ML | Limited availability | 2026-04-29 | 2027-04-29 | διαδικασία Εναλλακτικά άλλα σκευάσματα της ίδιας δραστικής κ |
| 🇬🇷 GR | BTx1VIALx2ML | Limited availability | 2026-04-29 | 2027-04-29 | διαδικασία περιεκτικότητας |
| 🇸🇪 SE | Gemcitabine Accord 100 mg/ml Koncentrat till infusionsvätska, lösning | Shortage | 2026-03-01 | 2026-08-31 | |
| 🇪🇸 ES | GEMCITABINA ACCORD 1500 mg CONCENTRADO PARA SOLUCION PARA PERFUSION , | Shortage | 2024-10-06 | 2026-11-29 | Existen otros medicamentos con el mismo principio activo y m |
| 🇩🇪 DE | Bendacitabin 38 mg/ml | Shortage | 2023-12-04 | 2027-01-31 | Probleme in der Herstellung |
Yes. As of 14 September 2026, availability issues are reported in: Germany, Spain, Greece, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-09-29 to 2027-04-29. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
5 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Gemcitabinhydrochlorid: BfArM (Germany), AEMPS CIMA (Spain), EOF limited-availability list (Greece), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Gemcitabinhydrochlorid — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/gemcitabinhydrochlorid/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Gemcitabinhydrochlorid availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/gemcitabinhydrochlorid/">Gemcitabinhydrochlorid shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>